No recent analyst price targets found for ALSE.
Latest News for ALSE
Financial Contrast: Alseres Pharmaceuticals (OTCMKTS:ALSE) vs. Relmada Therapeutics (NASDAQ:RLMD)
Relmada Therapeutics (NASDAQ: RLMD - Get Free Report) and Alseres Pharmaceuticals (OTCMKTS:ALSE - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations. Insider and Institutional Ownership 45.2% of Relmada Therapeutics
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ALSE.
U.S. House Trading
No House trades found for ALSE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.